Table 4.

Sensitivity and specificity by IBD type

	Crohn’s disease		Ulcerative colitis		p-value
	Estimate [CI]	N	Estimate [CI]	N
CRC sensitivity	55.6% [26.7–81.1%]	9	78.9% [56.7–91.5%]	19	0.3715
APL sensitivity	58.3% [32.0–80.7%]	12	90.5% [71.1–97.3%]	21	0.0709
Specificity [negative, non-AA]	86.9% [79.2–92.0%]	107	77.5% [70.9–82.9%]	182	0.0620

APL: advanced precancerous lesions [includes serrated lesions]; CRC: colorectal cancer; non-APL: non-advanced precancerous lesions.